James M Hotaling1, Aruna V Sarma2, Darshan P Patel3, Barbara H Braffett4, Patricia A Cleary4, Eva Feldman5, William H Herman5, Catherine L Martin5, Alan M Jacobson6, Hunter Wessells7, Rodica Pop-Busui5. 1. Department of Surgery (Urology), University of Utah, Salt Lake City, UT jim.hotaling@hsc.utah.edu. 2. Department of Urology, University of Michigan, Ann Arbor, MI. 3. Department of Surgery (Urology), University of Utah, Salt Lake City, UT. 4. Biostatistics Center, George Washington University, Rockville, MD. 5. Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI. 6. Research Institute, Winthrop University Hospital, Mineola, NY. 7. Department of Urology and Diabetes Endocrinology Research Center, University of Washington, Seattle, WA.
Abstract
OBJECTIVE: This study evaluated associations among cardiovascular autonomic neuropathy (CAN), female sexual dysfunction (FSD), and urinary incontinence (UI) in women with type I diabetes mellitus (T1DM). RESEARCH DESIGN AND METHODS: We studied 580 women with T1DM in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC). CAN was defined as: 1) R-R variation <15 with deep breathing or 2) R-R variation of 15-19.9 plus Valsalva ratio ≤1.5 or a supine-to-standing drop of 10 mmHg in diastolic blood pressure. A Sandvik Severity Index of 3-12 defined UI, and a Female Sexual Function Index (FSFI-R) score ≥22.75 defined FSD. Multivariable models estimated associations among CAN, FSD, and UI. RESULTS: At EDIC year 17, FSD was observed in 41% of women and UI in 30%. No statistically significant associations were observed between measures of CAN at DCCT closeout and subsequent report of FSD or UI. At EDIC year 16/17, there was a 53% increased odds of having UI with a Valsalva ratio ≤1.5. At both EDIC year 13/14 and EDIC year 16/17, a 5-unit increase in R-R variation was associated with a 1.11 greater odds of having FSD. CONCLUSIONS: In women with T1DM in the DCCT/EDIC, we found significant increased odds of FSD and UI with specific measures of CAN. In long-standing T1DM, CAN may predict development of FSD and may be a useful surrogate for generalized diabetic autonomic neuropathy.
OBJECTIVE: This study evaluated associations among cardiovascular autonomic neuropathy (CAN), female sexual dysfunction (FSD), and urinary incontinence (UI) in women with type I diabetes mellitus (T1DM). RESEARCH DESIGN AND METHODS: We studied 580 women with T1DM in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC). CAN was defined as: 1) R-R variation <15 with deep breathing or 2) R-R variation of 15-19.9 plus Valsalva ratio ≤1.5 or a supine-to-standing drop of 10 mmHg in diastolic blood pressure. A Sandvik Severity Index of 3-12 defined UI, and a Female Sexual Function Index (FSFI-R) score ≥22.75 defined FSD. Multivariable models estimated associations among CAN, FSD, and UI. RESULTS: At EDIC year 17, FSD was observed in 41% of women and UI in 30%. No statistically significant associations were observed between measures of CAN at DCCT closeout and subsequent report of FSD or UI. At EDIC year 16/17, there was a 53% increased odds of having UI with a Valsalva ratio ≤1.5. At both EDIC year 13/14 and EDIC year 16/17, a 5-unit increase in R-R variation was associated with a 1.11 greater odds of having FSD. CONCLUSIONS: In women with T1DM in the DCCT/EDIC, we found significant increased odds of FSD and UI with specific measures of CAN. In long-standing T1DM, CAN may predict development of FSD and may be a useful surrogate for generalized diabetic autonomic neuropathy.
Authors: S Tesfaye; L K Stevens; J M Stephenson; J H Fuller; M Plater; C Ionescu-Tirgoviste; A Nuber; G Pozza; J D Ward Journal: Diabetologia Date: 1996-11 Impact factor: 10.122
Authors: Martin Schönauer; Andreas Thomas; Stephan Morbach; Josef Niebauer; Ulrike Schönauer; Holger Thiele Journal: Diab Vasc Dis Res Date: 2008-11 Impact factor: 3.291
Authors: David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth Journal: N Engl J Med Date: 2003-06-05 Impact factor: 91.245
Authors: Shivani Bakre; Sarah K Holt; Mary Oerline; Barbara H Braffett; Rodica Pop-Busui; Hunter Wessells; Aruna V Sarma Journal: Neurourol Urodyn Date: 2021-10-21 Impact factor: 2.696
Authors: Rodica Pop-Busui; Barbara H Braffett; Hunter Wessells; William H Herman; Catherine L Martin; Alan M Jacobson; Aruna V Sarma Journal: Diabetes Care Date: 2022-01-01 Impact factor: 19.112
Authors: Elena Daskalaki; Anne Parkinson; Nicola Brew-Sam; Md Zakir Hossain; David O'Neal; Christopher J Nolan; Hanna Suominen Journal: J Med Internet Res Date: 2022-04-08 Impact factor: 7.076
Authors: Maren E H Buskoven; Eir K H Kjørholt; Ragnhild B Strandberg; Eirik Søfteland; Anne Haugstvedt Journal: Diabet Med Date: 2022-04-28 Impact factor: 4.213